https://beximcopharma.com/
Beyond BEXIMCO, SNH’s Global Innovation division has forged strategic partnerships with various healthcare companies. Collaborations with Searle Pharma and MGI have focused on cutting-edge pharmaceuticals, including treatments like Remdesivir. CNBG has also played a key role in genome sequencing, furthering research into genetic data and plasma-derived therapies.
In addition to these partnerships, Ganofax is another major initiative, where SNH focuses on innovative healthcare solutions that combine genetics, microbiome science, and artificial intelligence to improve global wellbeing. Ganofax’s approach integrates genetics and the gut microbiome to develop personalized health treatments
Lastly, SNH has ventured into mental health through Happence, a mental health and wellbeing program aimed at enhancing emotional resilience and supporting mental health through various wellness initiatives
These diverse ventures highlight SNH’s commitment to advancing both physical and mental health on a global scale.
Automated page speed optimizations for fast site performance